RASCHI, EMANUEL
RASCHI, EMANUEL
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E.
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
Symmetrical cutaneous rash in two women.
2024 Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M.
Antipsychotics and Drug-Induced Liver Injury
2023 Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; De Ponti, Fabrizio
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct
2023 Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E.
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events.
2023 Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A.
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
2023 Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
2023 Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, Rita; Potena, Luciano
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
2023 Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
2023 Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E.
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe
2023 Menniti-Ippolito, Francesca; Aiello, Eugenio; Arzenton, Elena; Assisi, Alessandro; Blaznik, Urška; Castenmiller, Jacqueline J. M.; Crevani, Marta; de Clock, Dominique; Di Giacomo, Silvia; Emendi, Silvia; Gonella, Laura Augusta; Ippoliti, Ilaria; Lindquist, Marie; Magro, Lara; Mazzanti, Gabriela; Mores, Nadia; Moretti, Ugo; Moro, Paola Angela; Novakovic, Budimka; Raschi, Emanuel; Siksna, Inese; Valetto, Maria Rosa; Vitalone, Annabella; Vo Van Regnault, Gwenn
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E.
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System
2023 Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R.
Interpretation of Pharmacovigilance Disproportionality Analyses
2023 Khouri, Charles; Fusaroli, Michele; Salvo, Francesco; Raschi, Emanuel
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
2023 Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E.; Khouri C.
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
2023 Gastaldon, C; Arzenton, E; Raschi, E; Spigset, O; Papola, D; Ostuzzi, G; Moretti, U; Trifirò, G; Barbui, C; Schoretsanitis, G
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2023 Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea; Guarino, Maria; Gelsomino, Francesco
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023 Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M.
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
2023 Goldman, Adam; Raschi, Emanuel; Chapman, Joab; Santomasso, Bianca D.; Pasquini, Marcelo C.; Perales, Miguel-Angel; Shouval, Roni
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY
2023 Raschi E.; Comito F.; Massari F.; Gelsomino F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS | Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-023-01391-4.pdf; 40264_2023_1391_MOESM1_ESM.docx |
| Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Symmetrical cutaneous rash in two women. | Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M. | 2024-01-01 | CLINICAL CASE REPORTS | - | 1.01 Articolo in rivista | - |
| Antipsychotics and Drug-Induced Liver Injury | Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; ...De Ponti, Fabrizio | 2023-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct | Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. | 2023-01-01 | ADDICTION | - | 1.01 Articolo in rivista | Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf |
| Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events. | Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A. | 2023-01-01 | PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Raschi E_Beyond statins_Pharmacol Ther.pdf |
| Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors | Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco | 2023-01-01 | JTO CLINICAL AND RESEARCH REPORTS | - | 1.01 Articolo in rivista | Sisi et al. JTO CCR 23.pdf; Sisi et al. JTO CCR supplementary 23.pdf |
| Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians | Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf; 40264_2023_1320_MOESM1_ESM.pdf |
| Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach | Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System | Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-022-01269-x.pdf; 40264_2022_1269_MOESM1_ESM.pdf |
| Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe | Menniti-Ippolito, Francesca; Aiello, Eugenio; Arzenton, Elena; Assisi, Alessandro; Blaznik, Urška...; Castenmiller, Jacqueline J. M.; Crevani, Marta; de Clock, Dominique; Di Giacomo, Silvia; Emendi, Silvia; Gonella, Laura Augusta; Ippoliti, Ilaria; Lindquist, Marie; Magro, Lara; Mazzanti, Gabriela; Mores, Nadia; Moretti, Ugo; Moro, Paola Angela; Novakovic, Budimka; Raschi, Emanuel; Siksna, Inese; Valetto, Maria Rosa; Vitalone, Annabella; Vo Van Regnault, Gwenn | 2023-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study | Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. | 2023-01-01 | PSYCHIATRY AND CLINICAL NEUROSCIENCES | - | 1.01 Articolo in rivista | Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf |
| Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System | Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R. | 2023-01-01 | JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH | - | 1.01 Articolo in rivista | 2022.09.05.22279609v3.full.pdf |
| Interpretation of Pharmacovigilance Disproportionality Analyses | Khouri, Charles; Fusaroli, Michele; Salvo, Francesco; Raschi, Emanuel | 2023-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.04 Replica / breve intervento (e simili) | - |
| Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study | Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E....; Khouri C. | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Fusaroli_2023.pdf; 40264_2023_1329_MOESM2_ESM.xlsx; 40264_2023_1329_MOESM1_ESM.pdf |
| Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database | Gastaldon, C; Arzenton, E; Raschi, E; Spigset, O; Papola, D; Ostuzzi, G; Moretti, U; Trifirò, G; ...Barbui, C; Schoretsanitis, G | 2023-01-01 | PSYCHOLOGICAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors | Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea...; Guarino, Maria; Gelsomino, Francesco | 2023-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Peripheral nervous system adverse events associated with immune checkpoint inhibitors | Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. | 2023-01-01 | JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | Rossi_JN_2023.pdf |
| Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells | Goldman, Adam; Raschi, Emanuel; Chapman, Joab; Santomasso, Bianca D.; Pasquini, Marcelo C.; Peral...es, Miguel-Angel; Shouval, Roni | 2023-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY | Raschi E.; Comito F.; Massari F.; Gelsomino F. | 2023-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |